ZLDAF
Zelira Therapeutics Limited

29
Mkt Cap
$4.96M
Volume
85.00
52W High
$0.4165
52W Low
$0.20
PE Ratio
-2.02
ZLDAF Fundamentals
Price
$0.4165
Prev Close
$0.2716
Open
$0.4165
50D MA
$0.3079
Beta
0.07
Avg. Volume
12.45
EPS (Annual)
-$0.2046
P/B
-1.70
$4.82
Loading...
Loading...

About

Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Zelira Therapeutics Limited?
What is the 52-week high for Zelira Therapeutics Limited?
What is the 52-week low for Zelira Therapeutics Limited?
What is Zelira Therapeutics Limited stock price today?
What was Zelira Therapeutics Limited stock price yesterday?
What is the PE ratio of Zelira Therapeutics Limited?
What is the Price-to-Book ratio of Zelira Therapeutics Limited?
What is the 50-day moving average of Zelira Therapeutics Limited?

Latest ZLDAF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.